Lignans: A Chemometric Analysis

Overview

Journal Molecules

Publisher MDPI

Specialty Biology

Date 2018 Jul 11

PMID 29987225

Citations 12

Authors

Lisa I Pilkington

Affiliations

Soon will be listed here.

Abstract

The physicochemical properties of classical lignans, neolignans, flavonolignans and carbohydrate-lignan conjugates (CLCs) were analysed to assess their ADMET profiles and establish if these compounds are / and thus have potential to be or act as leads in the development of future therapeutics. It was found that while no studied compounds were a very large proportion (>75%) fulfilled all the requirements to be deemed as present in space and almost all compounds studied were in the known drug space. Principal component analysis was an effective technique that enabled the investigation of the relationship between the studied molecular descriptors and was able to separate the lignans from their sugar derivatives and flavonolignans, primarily according to the parameters that are considered when defining chemical space (i.e., number of hydrogen bond donors, acceptors, rotatable bonds, polar surface area and molecular weight). These results indicate that while CLCs and flavonolignans are less lignans show a particularly high level of , an observation that coupled with their potent biological activities, demands future pursuit into their potential for use as therapeutics.

Citing Articles

Natural Phenolic Compounds with Antithrombotic and Antiplatelet Effects: A Drug-likeness Approach.

Fernandes D, Gomes A, da Silva C, de Medeiros Henriques I, Barros de Menezes R, Scotti M Curr Med Chem. 2024; 31(26):4138-4159.

PMID: 38375850 DOI: 10.2174/0109298673268452231108061008.

Therapeutic Potential of the Genus Phytochemicals: A Theoretical ADME/Tox Analysis.

Wekesa E, Kimani N, Kituyi S, Omosa L, Santos C S Afr J Bot. 2023; 162:129-141.

PMID: 37840557 PMC: 10569136. DOI: 10.1016/j.sajb.2023.09.009.

Extraction Techniques and Analytical Methods for Isolation and Characterization of Lignans.

Patyra A, Koltun-Jasion M, Jakubiak O, Kiss A Plants (Basel). 2022; 11(17).

PMID: 36079704 PMC: 9460740. DOI: 10.3390/plants11172323.

Lignans of Sesame ( L.): A Comprehensive Review.

Andargie M, Vinas M, Rathgeb A, Moller E, Karlovsky P Molecules. 2021; 26(4).

PMID: 33562414 PMC: 7914952. DOI: 10.3390/molecules26040883.

Virtual Screening and the In Vitro Assessment of the Antileishmanial Activity of Lignans.

Maia M, Raimundo E Silva J, de Lima Nunes T, de Sousa J, Rodrigues G, Monteiro A Molecules. 2020; 25(10).

PMID: 32408657 PMC: 7288103. DOI: 10.3390/molecules25102281.

References

Pan J, Chen S, Yang M, Wu J, Sinkkonen J, Zou K . An update on lignans: natural products and synthesis. Nat Prod Rep. 2009; 26(10):1251-92. DOI: 10.1039/b910940d. View

Pilkington L, Barker D . Asymmetric synthesis and CD investigation of the 1,4-benzodioxane lignans eusiderins A, B, C, G, L, and M. J Org Chem. 2012; 77(18):8156-66. DOI: 10.1021/jo3015006. View

Hann M, Keseru G . Finding the sweet spot: the role of nature and nurture in medicinal chemistry. Nat Rev Drug Discov. 2012; 11(5):355-65. DOI: 10.1038/nrd3701. View

Negi A, Kumar J, Luqman S, Shanker K, Gupta M, Khanuja S . Recent advances in plant hepatoprotectives: a chemical and biological profile of some important leads. Med Res Rev. 2007; 28(5):746-72. DOI: 10.1002/med.20115. View

Xu P, Huang M, Xiao C, Long F, Wang Y, Liu S . Matairesinol Suppresses Neuroinflammation and Migration Associated with Src and ERK1/2-NF-κB Pathway in Activating BV2 Microglia. Neurochem Res. 2017; 42(10):2850-2860. DOI: 10.1007/s11064-017-2301-1. View

Zhu F, Logan G, Reynisson J . Wine Compounds as a Source for HTS Screening Collections. A Feasibility Study. Mol Inform. 2016; 31(11-12):847-55. DOI: 10.1002/minf.201200103. View

Hanessian S, Reddy G, Chahal N . Total synthesis and stereochemical confirmation of manassantin A, B, and B1. Org Lett. 2006; 8(24):5477-80. DOI: 10.1021/ol0621710. View

Biedermann D, Vavrikova E, Cvak L, Kren V . Chemistry of silybin. Nat Prod Rep. 2014; 31(9):1138-57. DOI: 10.1039/c3np70122k. View

Rye C, Barker D . Asymmetric synthesis of (+)-galbelgin, (-)-kadangustin J, (-)-cyclogalgravin and (-)-pycnanthulignenes A and B, three structurally distinct lignan classes, using a common chiral precursor. J Org Chem. 2011; 76(16):6636-48. DOI: 10.1021/jo200968f. View

10.

Teponno R, Kusari S, Spiteller M . Recent advances in research on lignans and neolignans. Nat Prod Rep. 2016; 33(9):1044-92. DOI: 10.1039/c6np00021e. View

11.

Luo J, Chuang T, Cheung J, Quan J, Tsai J, Sullivan C . Masoprocol (nordihydroguaiaretic acid): a new antihyperglycemic agent isolated from the creosote bush (Larrea tridentata). Eur J Pharmacol. 1998; 346(1):77-9. DOI: 10.1016/s0014-2999(98)00139-3. View

12.

Hainsworth J, Greco F . Etoposide: twenty years later. Ann Oncol. 1995; 6(4):325-41. DOI: 10.1093/oxfordjournals.annonc.a059180. View

13.

Davidson S, Pearce A, Copp B, Barker D . Total Synthesis of (-)-Bicubebin A, B, (+)-Bicubebin C and Structural Reassignment of (-)-cis-Cubebin. Org Lett. 2017; 19(19):5368-5371. DOI: 10.1021/acs.orglett.7b02644. View

14.

Bade R, Chan H, Reynisson J . Characteristics of known drug space. Natural products, their derivatives and synthetic drugs. Eur J Med Chem. 2010; 45(12):5646-52. DOI: 10.1016/j.ejmech.2010.09.018. View

15.

Muchmore S, Edmunds J, Stewart K, Hajduk P . Cheminformatic tools for medicinal chemists. J Med Chem. 2010; 53(13):4830-41. DOI: 10.1021/jm100164z. View

16.

Paterson D, Barker D . Synthesis of the furo[2,3-b]chromene ring system of hyperaspindols A and B. Beilstein J Org Chem. 2015; 11:265-70. PMC: 4362291. DOI: 10.3762/bjoc.11.29. View

17.

Lu J, Crimin K, Goodwin J, Crivori P, Orrenius C, Xing L . Influence of molecular flexibility and polar surface area metrics on oral bioavailability in the rat. J Med Chem. 2004; 47(24):6104-7. DOI: 10.1021/jm0306529. View

18.

Canel C, Moraes R, Dayan F, Ferreira D . Podophyllotoxin. Phytochemistry. 2000; 54(2):115-20. DOI: 10.1016/s0031-9422(00)00094-7. View

19.

Lipinski C . Lead- and drug-like compounds: the rule-of-five revolution. Drug Discov Today Technol. 2014; 1(4):337-41. DOI: 10.1016/j.ddtec.2004.11.007. View

20.

Huang W, Cai Y, Zhang Y . Natural phenolic compounds from medicinal herbs and dietary plants: potential use for cancer prevention. Nutr Cancer. 2010; 62(1):1-20. DOI: 10.1080/01635580903191585. View